Four of the six patients were positive for anti-Ma2 autoantibodies; in these cases, the tumors were variously non-small-cell lung carcinoma (n = 2), renal carcinoma (n = 1), and mesothelioma (n = 1). This evidence concerns the gene PNMA2 and non-small cell lung carcinoma.